Media ReleaseMarking Immutep’s transition to a Phase III biotech, the Company’s pivotal TACTI-004 trial in first-line non-small cell lung cancer ...
Media Release Marking Immutep's transition to a Phase III biotech, the Company's pivotal TACTI-004 trial in first-line non-small cell lung cancer (1L NSCLC) received first regulatory approvalMature da ...
The five Oscar-nominated directors of photography for Best Cinematography break down why they chose the cameras and lenses ...
The consumer electronics industry was valued at approximately USD 3,296.66 million in 2023 and is projected to reach USD ...